about
Interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries: a systematic review and meta-analysisReported availability and gaps of pediatric palliative care in low- and middle-income countries: a systematic review of published dataSupportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries.Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomesPhase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumorsInterventions targeting absences increase adherence and reduce abandonment of childhood cancer treatment in El Salvador.Magnitude of Treatment Abandonment in Childhood Cancer.Patterns of End-of-Life Care in Children With Advanced Solid Tumor Malignancies Enrolled on a Palliative Care ServiceThe prioritisation of paediatrics and palliative care in cancer control plans in AfricaDeterminants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey.Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature.SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsRapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors.Best practices for pediatric palliative cancer care: a primer for clinical providers.A practical approach to reporting treatment abandonment in pediatric chronic conditions.Parathyroid Cancer in the Pediatric Patient.Well-directed inclusion of hematology in African national cancer control plans.Traditional and complementary medicine used with curative intent in childhood cancer: A systematic review.Physician Perspectives on Palliative Care for Children With Neuroblastoma: An International Context.Creating a student-led health magazine with an urban, multicultural, resource-restricted elementary school: Approach, process and impact.Hospital detention practices: statement of a global taskforce.Survey of quality, readability, and social reach of websites on osteosarcoma in adolescents.Global Use of Traditional and Complementary Medicine in Childhood Cancer: A Systematic Review.Defining and distinguishing treatment abandonment in patients with cancer.Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP).Community resources support adherence to treatment for childhood cancer in El Salvador.Improving retinoblastoma outcomes through a stage-based intervention model.The My Child Matters programme: effect of public-private partnerships on paediatric cancer care in low-income and middle-income countries.Assessing National Cancer Control Plan Knowledge, Prioritization, and Engagement Through a Pediatric Oncology Cancer Control Workshop.Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working GroupRevised versions of the Childhood Health Assessment Questionnaire (CHAQ) are more sensitive and suffer less from a ceiling effectComplete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitorEfficacy of intravenous Ig therapy in juvenile dermatomyositisOptimizing outcomes for children with non-Hodgkin lymphoma in low- and middle-income countries by early correct diagnosis, reducing toxic death and preventing abandonmentScience and health for all children with cancerPolitical priority and pathways to scale-up of childhood cancer care in five nations
P50
Q26776332-90EAFC8B-1536-481F-A767-59EF282457FFQ27002974-A2B42730-1D6B-4930-9CE8-517CFA9462D8Q33423131-86047F58-16C9-49B9-A608-D0AA67DA67D4Q34196347-AF8D1A0A-8D9B-4395-A047-8F35DC826987Q34725699-92F99F7C-63C6-472A-8026-C8C83F01C6D6Q35564717-485E64C6-0398-4A3E-908C-D87C182D3E47Q35793642-00BD84AF-E96D-457B-A4A4-4894E21C914DQ35998312-268988FB-FAAE-4DE3-B42D-A47BEFCB3CEAQ36086840-B2810E8C-07EA-4369-BEDD-D4B0AFEAAE28Q36162452-A4B048FC-4711-49E0-8F0C-071FF945D0BEQ36662921-7E82B474-BB2C-4340-AE0A-92231B6669BEQ37461968-E4B0BE07-5E16-4D50-842A-1F99C58B4CECQ37621405-CFEB7885-DFF0-4450-B944-6C5372474511Q38176636-4DDA16D0-5D6C-46FF-92A1-E2BB05881BD6Q38317315-783FDF6D-5770-4A7E-9FFE-8278973A83D5Q38663840-418F86A8-421A-4148-8076-4BE95C231674Q38944615-43FA653E-18A1-4F31-A274-8792B9666921Q39154292-92BE5BA2-F562-45D0-9B5F-2D427691B832Q39177884-8A051AEF-B60E-4C1F-A3BC-4DA4CDE43EA3Q39616036-8340BEAC-52E8-4D2A-936E-70CD3442A6E2Q40989138-4740E0B2-4F01-4CF5-BC6A-54551C3A1179Q46034032-8FAB3243-44A6-4CFA-9B1A-C07C85FB46A4Q47100440-71D561DB-6574-4951-AD42-941278958947Q47431147-2B67A6A1-127C-4E4A-B843-0C11F3139FEDQ47616676-B465C48F-48AA-478A-9681-B976E70EAFF6Q48317472-38DA77F0-068C-4EF8-AD3D-CEAF68E47EBBQ49923691-4092B103-50BB-4B9A-B762-A8C5B1A04F4EQ51804335-1C5948F8-324B-4A83-9E88-9A08D7D0EAD1Q53686249-3B8A12D7-ABD4-465C-835B-A2623664A5BCQ53731259-C911B2F2-DE05-4371-A6B8-6A8B8935827CQ59305550-6B8B9B80-4158-42D5-911A-286DFE3E3259Q60167878-D6BE2FAF-FBFB-4B78-9AC5-6BF50397ED6BQ73844698-0407B7D8-3FE4-4DC0-91B7-08578EB5E5CCQ85054518-AC5BC6EC-D004-45E5-AD8B-8C38D589D313Q91444154-7806DDF6-628E-4F7B-9D01-83598A53E5D1Q92370670-41E56258-5728-4B58-B9F5-B87B94E16AB4Q92697611-E62F9B8D-8244-44CE-9EDC-688E04EC8535
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Catherine G Lam
@ast
Catherine G Lam
@en
Catherine G Lam
@es
Catherine G Lam
@nl
Catherine G Lam
@sl
type
label
Catherine G Lam
@ast
Catherine G Lam
@en
Catherine G Lam
@es
Catherine G Lam
@nl
Catherine G Lam
@sl
prefLabel
Catherine G Lam
@ast
Catherine G Lam
@en
Catherine G Lam
@es
Catherine G Lam
@nl
Catherine G Lam
@sl
P1053
K-6328-2014
P106
P21
P31
P3829
P496
0000-0003-1363-5331